Literature DB >> 25608050

The polio endgame.

Philip Minor1.   

Abstract

Paralytic poliomyelitis is a disease that became a public health issue at the beginning of the twentieth century and was more or less eliminated in developed countries by the early 1970s. The Global Polio Eradication Initiative of WHO has now eradicated endemic polio from all but three countries although re-introductions occur. The progress in polio eradication is striking and has accelerated over the last few years. It is likely that it will be finally eradicated from the world soon, the looming issue will then be how to stop vaccinating or modify immunization programs safely so that poliomyelitis does not re-emerge. This review article discusses the history and pathogenesis of poliomyelitis. The progress made, and challenges in sustaining the eradication of this debilitating infectious disease are considered.

Entities:  

Keywords:  AFP, acute flaccid paralysis; IPV, inactivated polio vaccine; OPV, oral polio vaccine; VAPP, vaccine associated paralytic poliomyelitis; cVDPVs, circulating vaccine derived polioviruses; eradication; infectious disease; polio; poliomyelitis; tOPV, trivalent oral vaccine; vaccine

Mesh:

Substances:

Year:  2014        PMID: 25608050      PMCID: PMC4370356          DOI: 10.4161/21645515.2014.981115

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  2 in total

Review 1.  The polio-eradication programme and issues of the end game.

Authors:  Philip D Minor
Journal:  J Gen Virol       Date:  2011-11-29       Impact factor: 3.891

Review 2.  Role of environmental poliovirus surveillance in global polio eradication and beyond.

Authors:  T Hovi; L M Shulman; H van der Avoort; J Deshpande; M Roivainen; E M DE Gourville
Journal:  Epidemiol Infect       Date:  2011-08-18       Impact factor: 2.451

  2 in total
  9 in total

1.  Factors Associated with HPV Vaccination in Young Males.

Authors:  Kelli M Fuller; Leslie Hinyard
Journal:  J Community Health       Date:  2017-12

2.  Equivalent schedules of intradermal fractional dose versus intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis.

Authors:  Nishant Jaiswal; Shreya Singh; Amit Agarwal; Anil Chauhan; Kiran K Thumburu; Harpreet Kaur; Meenu Singh
Journal:  Cochrane Database Syst Rev       Date:  2019-12-19

3.  Lessons From the Polio Endgame: Overcoming the Failure to Vaccinate and the Role of Subpopulations in Maintaining Transmission.

Authors:  Kimberly M Thompson; Radboud J Duintjer Tebbens
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

4.  An outbreak of severe infections among Australian infants caused by a novel recombinant strain of human parechovirus type 3.

Authors:  Tiffanie M Nelson; Peter Vuillermin; Jason Hodge; Julian Druce; David T Williams; Rekha Jasrotia; Soren Alexandersen
Journal:  Sci Rep       Date:  2017-03-14       Impact factor: 4.379

5.  Mobilizing political support proved critical to a successful switch from tOPV to bOPV in Kano, Nigeria 2016.

Authors:  Bashir Abba; Sule Abdullahi; Samuel Bawa; Kabir Ibrahim Getso; Imam Wada Bello; Charles Korir; Audu Musa; Fiona Braka; Adamu Ningi; Peter Nsubuga; Richard Banda; Sisay G Tegegne; Faisal Shuaib; Usman Said Adamu; Sulaiman Haladu
Journal:  BMC Public Health       Date:  2018-12-13       Impact factor: 3.295

Review 6.  Evolutionary and Structural Overview of Human Picornavirus Capsid Antibody Evasion.

Authors:  Javier Orlando Cifuente; Gonzalo Moratorio
Journal:  Front Cell Infect Microbiol       Date:  2019-08-20       Impact factor: 5.293

Review 7.  Isatin derivatives as broad-spectrum antiviral agents: the current landscape.

Authors:  Tilal Elsaman; Malik Suliman Mohamed; Eyman Mohamed Eltayib; Hatem A Abdel-Aziz; Abualgasim Elgaili Abdalla; Muhammad Usman Munir; Magdi Awadalla Mohamed
Journal:  Med Chem Res       Date:  2022-01-13       Impact factor: 2.351

8.  Applying the Concept of Peptide Uniqueness to Anti-Polio Vaccination.

Authors:  Darja Kanduc; Candida Fasano; Giovanni Capone; Antonella Pesce Delfino; Michele Calabrò; Lorenzo Polimeno
Journal:  J Immunol Res       Date:  2015-10-19       Impact factor: 4.818

Review 9.  Yellow Fever: Integrating Current Knowledge with Technological Innovations to Identify Strategies for Controlling a Re-Emerging Virus.

Authors:  Robin D V Kleinert; Eduardo Montoya-Diaz; Tanvi Khera; Kathrin Welsch; Birthe Tegtmeyer; Sebastian Hoehl; Sandra Ciesek; Richard J P Brown
Journal:  Viruses       Date:  2019-10-17       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.